The Clinical Genetics and Screening Course
About 40 percent of diseases are influenced by genetics, patients increasingly want to know their inherited risk, and almost no nurse practitioner is offering the service. This course gives you the clinical competence and the business roadmap to integrate clinical genetics and screening into your practice – or launch a stand-alone genetics clinic – with a very low barrier to entry.
Low overhead. Solid margins. Cash or insurance.
The economics are rare: general profit runs $100 to $200 per consultation, the screening test itself can be marked up two to four times, and most patients pay for the test you send off – so startup cost outside this training is minimal. Patients can pay cash, and in many cases insurance covers it. All you add is basic phlebotomy and the knowledge to do it well.
7 CE Hrs - $499 Regular Price
An $8 billion market, doubling by 2030 – and barely served by NPs
Genetic screening is an $8 billion market expected to double in size by 2030. Roughly 40 percent of diseases are influenced by genetics, about 5 to 10 percent of cancers are hereditary, and some 80 percent of rare conditions have a genetic predisposition. Patients optimizing their health want to know their inherited risk so they can act on it – and demand is climbing fast. For the astute nurse practitioner entrepreneur, that is a solid new revenue source for an existing practice, or the basis for a stand-alone clinic.
The lowest-barrier service line you can add
Unlike most clinical offerings, genetics needs almost no capital. Basic phlebotomy and lab supplies are all the equipment required; a stand-alone can run out of a small office; integrating it into an established practice is, in the course's words, dirt cheap. Most patients pay for the testing you send off, so your cost outside this training is minimal – and the margins are solid: roughly $100 to $200 profit per consultation, with the screening test itself markable up two to four times.
Works cash or insurance, and bolts onto any practice
Patients can pay cash for the testing and counseling, and in many cases insurance covers it – the ACA requires many plans to cover USPSTF Grade A/B services with no cost-sharing. That flexibility means this fits any model: wellness, psychiatric, family, and primary care practices can all add it. The course gives you the current coding (including CPT 96041, effective 2025, and time-based E/M) so you actually get paid for the work.
A clinical foundation you can monetize
The course builds genuine clinical competence in genetics and then shows you exactly how to turn it into a service. Each area is both a skill and a billable application:
Foundational genetics – your clinical credibility. Inheritance patterns, variant classification (pathogenic, likely pathogenic, VUS) to ACMG/AMP standards, penetrance, and genotype-phenotype relationships. The fluency that makes the service defensible.
Screening across disease areas – your service menu. Hereditary cancer, cardiovascular and lipid disorders, renal disease, metabolic and endocrine conditions, pulmonary genetics, and pharmacogenomics – each a reason a patient tests and returns.
The screening visit – your billable encounter. Family history and pedigree, test selection, informed consent, documentation, result disclosure, and follow-up, structured as a repeatable workflow.
Labs, coding, and the business – your revenue engine. Choosing testing platforms, insurance vs. cash models, CPT/ICD-10 coding, pricing structures, risk management, and ethical marketing.
Course Expires: 9/30/29
What you will be able to do, and build a service around
By the end of this course you will be able to:
Describe foundational genetic principles and interpret results to current ACMG/AMP standards, including pathogenic, likely pathogenic, and VUS findings. Accurate interpretation is what makes the service credible, defensible, and repeatable.
Identify indications for multigene panel testing across hereditary cancer, cardiovascular, renal, lipid, pulmonary, metabolic, and endocrine conditions, applying NCCN, ACMG, ASCO, ACOG, and USPSTF guidelines. A broad, guideline-based menu is a larger addressable patient base.
Perform a three-generation family history, construct a pedigree, and deliver informed consent and non-deterministic risk communication. This is the structured, billable visit the whole service runs on.
Compare testing platforms and labs on panel composition, turnaround, billing models, and counseling support. Choosing the right lab protects your margin and your outcomes.
Establish or expand genetic services as a line within your practice or a stand-alone clinic – including regulatory considerations, billing, and pricing – turning clinical competence into a low-overhead revenue source.
The clinical engine, framed as your service
Your Clinical Credibility: Foundational Genetics
Inheritance patterns, variant interpretation to ACMG/AMP standards (pathogenic, likely pathogenic, VUS), penetrance and expressivity, and the differences between genetics, genomics, pharmacogenomics, epigenetics, and polygenic risk. This is the fluency that lets you offer a defensible, premium service rather than a commodity test.
Your Service Menu: Screening Across Disease Areas
Hereditary cancer syndromes (including BRCA and Lynch) with guideline-based screening, cardiovascular and lipid genetics, renal disease and nephrolithiasis, monogenic diabetes and endocrine conditions, pulmonary genetics, metabolic and epigenetic genes (MTHFR, COMT, CBS), and pharmacogenomics. Every disease area is another reason a patient tests – and another line on your service menu.
Your Billable Encounter: The Screening Visit
Three-generation family history and pedigree construction, red-flag recognition, test selection, informed consent, documentation, result disclosure, and follow-up planning – built into a repeatable workflow. Structured well, each visit is a clean, documented, billable encounter that also sets up the next one.
Your Revenue Engine: Labs, Coding & the Business
Comparing labs and platforms, cash vs. insurance models, current CPT and ICD-10 coding (CPT 96041 effective 2025, time-based E/M, Z71.83 and Z15 codes), pricing structures, and the roughly $100 to $200 consultation profit plus a two-to-four-times test markup. This is how the clinical work becomes revenue – and how you get paid for it under either model.
Your Protection: Risk, Ethics & Compliance
Scope and liability, GINA and HIPAA protections, the limits around life, disability, and long-term-care insurance, informed consent, and ethical marketing that avoids genetic determinism. Delivered within scope and well documented, the risk is comparable to other cognitive clinical services – and that protection is what keeps the revenue defensible.
Justin Allan, FNP
Owner and operator of Elite NP, who built a cash-based practice from $0 to $70,000 a month in 2.5 years across two men's health clinics and a medical cannabis clinic. He teaches the cash-practice and service-line model that makes a new offering like genetics profitable from the start.
Brendan Tennefoss, DNP, AGPCNP-BC, ACHPN, AFMC
Founder of Metta Wellness NW, a telemedicine integrative and functional medicine practice specializing in men's health, TRT, peptide therapy, gut health, and thyroid optimization, with primary care, regenerative medicine, and hospice and palliative care experience. He brings the clinical depth that makes this a defensible, guideline-based genetics service. You are learning both the medicine and the business from people who run practices built on exactly this model.
Frequently asked questions
How do I actually make money with genetic screening?
General profit runs about $100 to $200 per consultation, and the screening test itself can be marked up two to four times. Most patients pay for the testing you send off, so your cost outside this training is minimal. It works cash or insurance, and because overhead is so low, the margin is solid from your first patient.
Do I need special equipment or a big investment?
No. Basic phlebotomy and lab supplies are all that is needed. A stand-alone can run from a small office, and integrating genetics into an existing practice is inexpensive – one of the lowest-barrier service lines you can add.
Is genetic testing within my scope as an NP?
Generally yes – any nurse practitioner has genetic testing within scope (acute care can be an exception). The course keeps you safe with ACMG/AMP interpretation, guideline application, informed consent, and risk management, and you refer to genetic counseling or specialty care when indicated.
Will insurance cover it, or is this cash-only?
Both. Patients can pay cash, and in many cases insurance covers the testing and counseling – the ACA requires many plans to cover USPSTF Grade A/B services with no cost-sharing. The course covers current CPT and ICD-10 coding (including CPT 96041, effective 2025) so you can bill correctly.
Can I add this to my existing practice, or does it need to be stand-alone?
Either. It integrates into wellness, psychiatric, family, and primary care practices as a new service line, or it can be a stand-alone clinic. The course covers both paths, including pricing and marketing.